Related references
Note: Only part of the references are listed.Tuning Nanoparticle Interactions with Ovarian Cancer through Layer-by-Layer Modification of Surface Chemistry
Santiago Correa et al.
ACS NANO (2020)
The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression
Yuqing Wu et al.
MOLECULAR CANCER (2020)
27-Hydroxycholesterol Impairs Plasma Membrane Lipid Raft Signaling as Evidenced by Inhibition of IL6-JAK-STAT3 Signaling in Prostate Cancer Cells
Shweta Dambal et al.
MOLECULAR CANCER RESEARCH (2020)
The effects of taurine supplementation on oxidative stress indices and inflammation biomarkers in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial
Vahid Maleki et al.
DIABETOLOGY & METABOLIC SYNDROME (2020)
Modulation of aryl hydrocarbon receptor inhibits esophageal squamous cell carcinoma progression by repressing COX2/PGE2/STAT3 axis
Peiyao Zhu et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2020)
CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3
Susana P. Egusquiaguirre et al.
NEOPLASIA (2020)
Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells
Alyssa D. Smith et al.
CANCER RESEARCH (2020)
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies
Yi-Zhou Jiang et al.
CANCER CELL (2019)
Breast Cancer Treatment
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Solution Conditions Tune and Optimize Loading of Therapeutic Polyelectrolytes into Layer-by-Layer Functionalized Liposomes
Santiago Correa et al.
ACS NANO (2019)
Treatment of Nonmetastatic Breast Cancer
Kathryn J. Ruddy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Jiang-Jiang Qin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Cellular Plasmalogen Content Does Not Influence Arachidonic Acid Levels or Distribution in Macrophages: A Role for Cytosolic Phospholipase A2γ in Phospholipid Remodeling
Patricia Lebrero et al.
CELLS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Targeting the enzymes involved in arachidonic acid metabolism to improve radiotherapy
Wanyeon Kim et al.
CANCER AND METASTASIS REVIEWS (2018)
JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
Tianyi Wang et al.
CELL METABOLISM (2018)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide
Lu Lu et al.
ONCOGENE (2018)
Jak-TGFβ cross-talk links transient adipose tissue inflammation to beige adipogenesis
Rohollah Babaei et al.
SCIENCE SIGNALING (2018)
Jak-TGFβ cross-talk links transient adipose tissue inflammation to beige adipogenesis
Rohollah Babaei et al.
SCIENCE SIGNALING (2018)
The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer
Mohammad W. Khan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
Xiaolan Zhu et al.
ONCOTARGET (2017)
A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non-Small Cell Lung Cancer
Li Gu et al.
CLINICAL CANCER RESEARCH (2017)
Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery
Fleur Weeber et al.
CELL CHEMICAL BIOLOGY (2017)
A poly(L-glutamic acid)-combretastatin A4 conjugate for solid tumor therapy: Markedly improved therapeutic efficiency through its low tissue penetration in solid tumor
Tianzhou Liu et al.
ACTA BIOMATERIALIA (2017)
Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2/PGE2/STAT3 axis
Dali Tong et al.
CANCER LETTERS (2017)
Identification of a gain-of-function STAT3 mutation (p.Y640F) in lymphocytic variant hypereosinophilic syndrome
Sarah Walker et al.
BLOOD (2016)
Highly Scalable, Closed-Loop Synthesis of Drug-Loaded, Layer-by-Layer Nanoparticles
Santiago Correa et al.
ADVANCED FUNCTIONAL MATERIALS (2016)
Targeting transcription factors by small compounds-Current strategies and future implications
Judith Hagenbuchner et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Gene expression-based discovery of atovaquone as a STAT3 inhibitor and anticancer agent
Michael Xiang et al.
BLOOD (2016)
A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo
Christopher G. Hubert et al.
CANCER RESEARCH (2016)
Engineering nanolayered particles for modular drug delivery
Santiago Correa et al.
JOURNAL OF CONTROLLED RELEASE (2016)
GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity
Sharon M. Louie et al.
Cell Chemical Biology (2016)
Nanoscaled Poly(L-glutamic acid)/Doxorubicin-Amphiphile Complex as pH-responsive Drug Delivery System for Effective Treatment of Nonsmall Cell Lung Cancer
Mingqiang Li et al.
ACS APPLIED MATERIALS & INTERFACES (2013)
Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
Zhou J. Deng et al.
ACS NANO (2013)
Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity
Daniel I. Benjamin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
N-Acyl Taurines are Anti-Proliferative in Prostate Cancer Cells
Vicky Chatzakos et al.
LIPIDS (2012)
Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways
Ayumi Takakura et al.
HUMAN MOLECULAR GENETICS (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Controlling in Vivo Stability and Biodistribution in Electrostatically Assembled Nanoparticles for Systemic Delivery
Zhiyong Poon et al.
NANO LETTERS (2011)
Physiological roles of taurine in heart and muscle
Stephen W. Schaffer et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas
K. Thornber et al.
ONCOGENE (2009)
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
Erik A. Nelson et al.
BLOOD (2008)
Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors
JV Alvarez et al.
CANCER RESEARCH (2005)
Requirement of matrix metalloproteinase-9 for the transformation of human mammary epithelial cells by Stat3-C
TN Dechow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
